AU2002234799A1 - Gene expression profiling of primary breast carcinomas using arrays of candidate genes - Google Patents
Gene expression profiling of primary breast carcinomas using arrays of candidate genesInfo
- Publication number
- AU2002234799A1 AU2002234799A1 AU2002234799A AU3479902A AU2002234799A1 AU 2002234799 A1 AU2002234799 A1 AU 2002234799A1 AU 2002234799 A AU2002234799 A AU 2002234799A AU 3479902 A AU3479902 A AU 3479902A AU 2002234799 A1 AU2002234799 A1 AU 2002234799A1
- Authority
- AU
- Australia
- Prior art keywords
- arrays
- gene expression
- expression profiling
- candidate genes
- primary breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25409000P | 2000-12-08 | 2000-12-08 | |
US60/254,090 | 2000-12-08 | ||
PCT/IB2001/002811 WO2002046467A2 (en) | 2000-12-08 | 2001-12-07 | Gene expression profiling of primary breast carcinomas using arrays of candidate genes |
US10/007,926 US20030143539A1 (en) | 2000-12-08 | 2001-12-07 | Gene expression profiling of primary breast carcinomas using arrays of candidate genes |
US10/007,926 | 2001-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002234799A1 true AU2002234799A1 (en) | 2002-06-18 |
Family
ID=26677525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002234799A Abandoned AU2002234799A1 (en) | 2000-12-08 | 2001-12-07 | Gene expression profiling of primary breast carcinomas using arrays of candidate genes |
Country Status (6)
Country | Link |
---|---|
US (3) | US20030143539A1 (en) |
EP (1) | EP1353947A2 (en) |
JP (2) | JP2004537261A (en) |
AU (1) | AU2002234799A1 (en) |
CA (1) | CA2430981A1 (en) |
WO (1) | WO2002046467A2 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7645441B2 (en) * | 2000-12-22 | 2010-01-12 | Sagres Discovery Inc. | Compositions and methods in cancer associated with altered expression of PRLR |
US7820447B2 (en) | 2000-12-22 | 2010-10-26 | Sagres Discovery Inc. | Compositions and methods for cancer |
WO2002099421A2 (en) * | 2001-05-18 | 2002-12-12 | Thomas Jefferson University | Specific microarrays for breast cancer screening |
DK2799555T3 (en) | 2002-03-13 | 2017-05-22 | Genomic Health Inc | Gene Expression Profiling in Tumor Tissue Biopsies |
EP1361433A3 (en) * | 2002-04-09 | 2005-02-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method for estimating therapeutic efficacy of tumor necrosis factor (TNF) |
DE10229391A1 (en) * | 2002-06-29 | 2004-01-29 | Forschungszentrum Karlsruhe Gmbh | Biochip, useful for identifying metastatizing tumors and assessing metastatic potential, carries cDNA copies of genes with metastasis-specific expression and of control genes |
EP1382969A1 (en) | 2002-07-17 | 2004-01-21 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Diagnosis and prevention of cancer cell invasion |
US7074911B2 (en) * | 2002-09-25 | 2006-07-11 | Board Of Regents, The University Of Texas System | Endogenous granzyme B in non-immune cells |
CA2506066A1 (en) | 2002-11-15 | 2004-06-03 | Genomic Health, Inc. | Gene expression profiling of egfr positive cancer |
AU2012206980B2 (en) * | 2003-01-15 | 2015-02-05 | Genomic Health, Inc. | Gene expression markers for breast cancer prognosis |
US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
PT1597391E (en) | 2003-02-20 | 2008-12-19 | Genomic Health Inc | Use of intronic rna to measure gene expression |
US20040229225A1 (en) * | 2003-05-16 | 2004-11-18 | Jose Remacle | Determination of a general three-dimensional status of a cell by multiple gene expression analysis on micro-arrays |
WO2004111603A2 (en) * | 2003-05-28 | 2004-12-23 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
CA2530738C (en) * | 2003-06-24 | 2020-01-21 | Genomic Health, Inc. | Prediction of likelihood of cancer recurrence |
CA2531967C (en) | 2003-07-10 | 2013-07-16 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
EP1522594A3 (en) * | 2003-10-06 | 2005-06-22 | Bayer HealthCare AG | Methods and kits for investigating cancer |
EP1538218A1 (en) * | 2003-12-04 | 2005-06-08 | Erasmus University Medical Center Rotterdam | Method to diagnose or screen for inflammatory diseases |
WO2005064019A2 (en) | 2003-12-23 | 2005-07-14 | Genomic Health, Inc. | Universal amplification of fragmented rna |
JP2005270093A (en) * | 2004-02-24 | 2005-10-06 | Nippon Medical School | Gene participating in estimating postoperative prognosis of breast cancer |
WO2005080570A1 (en) | 2004-02-24 | 2005-09-01 | Mitsubishi Rayon Co., Ltd. | Gene relating to estimation of postoperative prognosis for breast cancer |
AU2005233593B2 (en) | 2004-04-09 | 2010-08-26 | Fondazione Irccs Istituto Nazionale Dei Tumori | Gene expression markers for predicting response to chemotherapy |
US7587279B2 (en) | 2004-07-06 | 2009-09-08 | Genomic Health | Method for quantitative PCR data analysis system (QDAS) |
US20060063184A1 (en) * | 2004-09-09 | 2006-03-23 | Felix Carolyn A | Compositions and methods for the detection of DNA topoisomerase II complexes with DNA |
PL1836629T3 (en) | 2004-11-05 | 2020-06-15 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
US7622251B2 (en) | 2004-11-05 | 2009-11-24 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
US20070072175A1 (en) * | 2005-05-13 | 2007-03-29 | Biogen Idec Ma Inc. | Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof |
TW200729050A (en) | 2005-09-22 | 2007-08-01 | China Synthetic Rubber Corp | Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas |
EP2177910A1 (en) * | 2005-11-10 | 2010-04-21 | Aurelium Biopharma Inc. | Tissue diagnostics for breast cancer |
JP5209505B2 (en) | 2006-02-10 | 2013-06-12 | ジェネンテック, インコーポレイテッド | Anti-FGF19 antibody and method of use thereof |
EP2338898A1 (en) | 2006-03-09 | 2011-06-29 | The Board of Regents of the University of Texas System | Compositions and methods related to profiling a plurality of cell lines based on peptide binding |
WO2008123867A1 (en) * | 2007-04-05 | 2008-10-16 | Source Precision Medicine, Inc. | Gene expression profiling for identification, monitoring, and treatment of breast cancer |
AU2008299779B2 (en) | 2007-08-03 | 2013-05-16 | Genentech, Inc. | Humanized anti-FGF19 antagonists and methods using same |
JP2012511323A (en) * | 2008-12-10 | 2012-05-24 | イプソゲン | Method for identifying ERBB2 changes in tumors |
CA2749947A1 (en) * | 2009-01-30 | 2010-08-05 | Bayer Healthcare Llc | Methods for treating estrogen receptor positive cancer by x-box binding protein 1 inhibition |
EP2764364B1 (en) | 2011-10-06 | 2021-08-18 | Aveo Pharmaceuticals, Inc. | Predicting tumor response to anti-erbb3 antibodies |
US9575115B2 (en) | 2012-10-11 | 2017-02-21 | Globalfoundries Inc. | Methodology of grading reliability and performance of chips across wafer |
US9169509B2 (en) | 2013-01-15 | 2015-10-27 | Board Of Regents, The University Of Texas System | Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity |
JP7144934B2 (en) | 2015-03-25 | 2022-09-30 | ザ ジェネラル ホスピタル コーポレイション | Digital analysis of circulating tumor cells in blood samples |
US11371101B2 (en) | 2016-10-27 | 2022-06-28 | The General Hospital Corporation | Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
WO2000024940A1 (en) * | 1998-10-28 | 2000-05-04 | Vysis, Inc. | Cellular arrays and methods of detecting and using genetic disorder markers |
-
2001
- 2001-12-07 CA CA002430981A patent/CA2430981A1/en not_active Abandoned
- 2001-12-07 WO PCT/IB2001/002811 patent/WO2002046467A2/en active Application Filing
- 2001-12-07 JP JP2002548184A patent/JP2004537261A/en active Pending
- 2001-12-07 US US10/007,926 patent/US20030143539A1/en not_active Abandoned
- 2001-12-07 EP EP01985452A patent/EP1353947A2/en not_active Ceased
- 2001-12-07 AU AU2002234799A patent/AU2002234799A1/en not_active Abandoned
-
2008
- 2008-01-25 JP JP2008014752A patent/JP4388983B2/en not_active Expired - Fee Related
-
2010
- 2010-10-13 US US12/903,594 patent/US20110086765A1/en not_active Abandoned
-
2011
- 2011-05-26 US US13/116,518 patent/US20130079234A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110086765A1 (en) | 2011-04-14 |
JP2004537261A (en) | 2004-12-16 |
WO2002046467A2 (en) | 2002-06-13 |
CA2430981A1 (en) | 2002-06-13 |
WO2002046467A3 (en) | 2003-08-28 |
US20030143539A1 (en) | 2003-07-31 |
JP2008178411A (en) | 2008-08-07 |
US20130079234A1 (en) | 2013-03-28 |
EP1353947A2 (en) | 2003-10-22 |
JP4388983B2 (en) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002234799A1 (en) | Gene expression profiling of primary breast carcinomas using arrays of candidate genes | |
AU2002259196A1 (en) | Gene expression profiling | |
AU2002362454A1 (en) | Regulated breast cancer genes | |
AU2001286643A1 (en) | Gene discovery using microarrays | |
AU2002345089A1 (en) | Synthetic double stranded oligonucleotides for targeted inhibition of gene expression | |
AU2003276852A1 (en) | Reading of fluorescent arrays | |
AU2002313559A1 (en) | Genes | |
AU2001278918A1 (en) | Novel lipase genes | |
ATE317007T1 (en) | GENES OF THE 1-DESOXY-D-XYLULOSE BIOSYNTHESIS PATHWAY | |
AU8005598A (en) | New uses for compounds which reduce (c-jun) gene expression | |
AU2001251069A1 (en) | Gene profiling arrays | |
AU2001269472A1 (en) | Fungal cell wall synthesis gene | |
AU2002214576A1 (en) | Genes related to development of refractory prostate cancer | |
IL153651A0 (en) | Fungal cell wall synthesis gene | |
AU2002360345A1 (en) | Prostate cancer genes | |
AU2003224598A1 (en) | Differentially-regulated prostate cancer genes | |
AU2001227903A1 (en) | Everninomicin biosynthetic genes | |
AU1140101A (en) | Improved mutation analysis of the nf1 gene | |
AU7709300A (en) | Drug discovery using gene expression profiling | |
AU2003212826A1 (en) | Cancer genes | |
AU2003285583A1 (en) | Oligonucleotide guided analysis of gene expression | |
AU2003282564A8 (en) | Gene profiling of single or multiple cells | |
AU3244801A (en) | Modified DHPS genes | |
AU2001266740A1 (en) | Promoters for regulated gene expression | |
AU2003282709A1 (en) | Gene expression profiling of bladder cancer |